Cargando…

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

In recent years, several important advances have been made in our understanding of the pathways that lead to cell dysfunction and death in Parkinson's disease (PD) and Huntington's disease (HD). Despite distinct clinical and pathological features, these two neurodegenerative diseases share...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franco-Iborra, Sandra, Vila, Miquel, Perier, Celine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974257/ https://www.ncbi.nlm.nih.gov/pubmed/29875626 http://dx.doi.org/10.3389/fnins.2018.00342

Ejemplares similares

Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson’s disease
por: Franco-Iborra, Sandra, et al.
Publicado: (2018)

Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
por: Tassone, Annalisa, et al.
Publicado: (2023)

Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles
por: Labadorf, Adam, et al.
Publicado: (2018)

Abnormal Mitochondrial Quality Control in Neurodegenerative Diseases
por: Yan, Xu, et al.
Publicado: (2020)

Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases
por: Gardoni, Fabrizio, et al.
Publicado: (2015)

SIRT3 Regulation of Mitochondrial Quality Control in Neurodegenerative Diseases
por: Meng, Hao, et al.
Publicado: (2019)

Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?
por: Hu, Di, et al.
Publicado: (2021)

Excitatory Dendritic Mitochondrial Calcium Toxicity: Implications for Parkinson’s and Other Neurodegenerative Diseases
por: Verma, Manish, et al.
Publicado: (2018)

Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease
por: Poletti, Barbara, et al.
Publicado: (2022)

Neurodegenerative processes in Huntington's disease
por: Bano, D, et al.
Publicado: (2011)

Mitochondrial quality control and neurodegenerative diseases
por: Gao, Fei, et al.
Publicado: (2018)

Exosomes and Homeostatic Synaptic Plasticity Are Linked to Each other and to Huntington's, Parkinson's, and Other Neurodegenerative Diseases by Database-Enabled Analyses of Comprehensively Curated Datasets
por: Wang, James K. T., et al.
Publicado: (2017)

Modulation of Mitochondrial Dynamics in Neurodegenerative Diseases: An Insight Into Prion Diseases
por: Zhu, Ting, et al.
Publicado: (2018)

Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson’s disease and Huntington’s disease
por: Novotný, Michal, et al.
Publicado: (2016)

Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease
por: Krashia, Paraskevi, et al.
Publicado: (2019)

Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases
por: Grieco, Maddalena, et al.
Publicado: (2019)

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases
por: Jagaran, Keelan, et al.
Publicado: (2021)

Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics
por: Pérez-Arancibia, Rodrigo, et al.
Publicado: (2023)

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
por: Chin-Chan, Miguel, et al.
Publicado: (2015)

On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2020)

Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011)

Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017)

Acanthocytes Identified in Huntington’s Disease
por: Yu, Yueyi, et al.
Publicado: (2022)

Motor–Language Coupling in Huntington’s Disease Families
por: Kargieman, Lucila, et al.
Publicado: (2014)

Editorial: Mitochondrial dysfunction as a target in neurodegenerative diseases
por: Perrone, Lorena
Publicado: (2023)

Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
por: Belloli, Sara, et al.
Publicado: (2020)

Mitochondrial Homeostasis and Signaling in Parkinson’s Disease
por: Scorziello, Antonella, et al.
Publicado: (2020)

Prion‐like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer’s, Parkinson’s, and Huntington’s Diseases and Amyotrophic Lateral Sclerosis
por: Ciurea, Alexandru Vlad, et al.
Publicado: (2023)

Mitochondrial Quality Control: Decommissioning Power Plants in Neurodegenerative Diseases
por: Mukherjee, Rukmini, et al.
Publicado: (2013)

Neuregulins in Neurodegenerative Diseases
por: Ou, Guan-yong, et al.
Publicado: (2021)

Sphingolipids in neurodegenerative diseases
por: Pan, Xueyang, et al.
Publicado: (2023)

Corticostriatal Dysfunction in Huntington’s Disease: The Basics
por: Bunner, Kendra D., et al.
Publicado: (2016)

Microglial Activation in the Pathogenesis of Huntington’s Disease
por: Yang, Hui-Ming, et al.
Publicado: (2017)

Cortical and Striatal Circuits in Huntington’s Disease
por: Blumenstock, Sonja, et al.
Publicado: (2020)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Altered Cholesterol Homeostasis in Huntington’s Disease
por: Kacher, Radhia, et al.
Publicado: (2022)

Cannabinoid signaling and risk in Huntington's disease
por: Humble, James, et al.
Publicado: (2022)

Commentary: Acanthocytes identified in Huntington's disease
por: Peikert, Kevin, et al.
Publicado: (2022)

Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease kinases, GTPases, and ATPases
por: Taymans, Jean-Marc, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7ls6l1vos60gbu48lor0siod84